Get the Stockscreener App
184.68
8.50%
-17.86
Iqvia Holdings Inc stock is traded at $184.68, with a volume of 2.82M.
It is down -8.50% in the last 24 hours and down -21.00% over the past month.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
See More
Previous Close:
$202.54
Open:
$199.88
24h Volume:
2.82M
Relative Volume:
1.98
Market Cap:
$31.47B
Revenue:
$15.90B
Net Income/Loss:
$1.28B
P/E Ratio:
25.35
EPS:
7.2842
Net Cash Flow:
$2.21B
1W Performance:
-21.34%
1M Performance:
-21.00%
6M Performance:
+0.76%
1Y Performance:
-9.79%
1-Day Range:
$182.41
$199.88
1-Week Range:
$182.41
$234.87
52-Week Range:
$134.65
$247.04
Iqvia Holdings Inc Stock (IQV) Company Profile
Name
Iqvia Holdings Inc
Sector
Industry
Phone
919-998-2000
Address
2400 ELLIS ROAD, DURHAM, NC
Compare IQV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
184.82 | 34.49B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
TMO
Thermo Fisher Scientific Inc
|
548.97 | 212.36B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
216.41 | 155.19B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
644.60 | 51.34B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
130.56 | 37.70B | 6.95B | 1.30B | 1.15B | 4.5696 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Nov-03-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-29-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-09-25 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-09-25 | Upgrade | Jefferies | Hold → Buy |
| Apr-25-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-10-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-03-25 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-20-24 | Initiated | Stephens | Overweight |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-04-24 | Initiated | RBC Capital Mkts | Outperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| Jun-06-24 | Initiated | Goldman | Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-15-24 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-13-24 | Initiated | BTIG Research | Buy |
| Nov-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Mar-17-23 | Initiated | Truist | Buy |
| Dec-06-22 | Initiated | Cowen | Outperform |
| Nov-17-22 | Downgrade | Citigroup | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-29-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-16-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-08-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jul-07-20 | Initiated | Stephens | Equal-Weight |
| Mar-02-20 | Initiated | Deutsche Bank | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Dec-13-19 | Upgrade | CFRA | Sell → Hold |
| Nov-14-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-21-19 | Upgrade | Mizuho | Neutral → Buy |
| May-28-19 | Initiated | SVB Leerink | Outperform |
| Jan-18-19 | Upgrade | Jefferies | Hold → Buy |
| Oct-09-18 | Initiated | UBS | Buy |
| Oct-02-18 | Reiterated | Robert W. Baird | Outperform |
| Jul-25-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-25-18 | Reiterated | Stifel | Buy |
| Jul-03-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-13-18 | Upgrade | Goldman | Neutral → Buy |
| Mar-07-18 | Upgrade | SunTrust | Hold → Buy |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
View All
Iqvia Holdings Inc Stock (IQV) Latest News
IQVIA (IQV) Shares Dip Despite Beating Q4 2025 Expectations - GuruFocus
IQVIA's (IQV) 2026 Earnings Forecast Falls Short Amid Rising Int - GuruFocus
IQVIA forecasts weak annual profit on higher interest expenses - marketscreener.com
Real-World Data on Healthcare Technology Adoption: Company Insights and Government Trends with Key Statistics (e.g., 71% U.S. Hospitals Adoption, $3B Company Valuations) - GlobeNewswire Inc.
IQVIA Q4 2025 slides: Revenue jumps 10.3%, stock falls despite beat - Investing.com India
IQVIA stock slides after Q4 results on outlook (IQV:NYSE) - Seeking Alpha
Earnings call transcript: IQVIA Q4 2025 beats forecasts, stock drops - Investing.com
IQVIA Holdings Inc. Provides Earnings Guidance for Full Year 2026 - marketscreener.com
IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance - PharmiWeb.com
IQV Announces 2026 Financial Projections with Strong Earnings Ou - GuruFocus
Iqvia shares down 6.48% after co forecasts 2026 profit below estimates - marketscreener.com
Iqvia (IQV) Q4 Revenue Surpasses Expectations with Strong Segmen - GuruFocus
IQVIA Holdings Inc (NYSE:IQV) Beats Q4 Revenue Estimates and Issues 2026 Guidance - Chartmill
IQVIA Holdings (IQV) Q4 Earnings and Revenues Top Estimates - Yahoo! Finance Canada
(IQV) IQVIA Expects 2026 Adjusted EPS Range $12.55 to $12.85, vs. FactSet Est of $12.93 - marketscreener.com
IQVIA: Q4 Earnings Snapshot - kens5.com
IQVIA: Fourth Quarter Financial Highlights - Bitget
IQV: Strong Q4 and 2025 results with positive 2026 outlook and strategic segment realignment - TradingView
A Look At IQVIA Holdings (IQV) Valuation After Recent Share Price Volatility - Yahoo Finance
IQVIA Holdings earnings on deck amid clinical research trends By Investing.com - Investing.com UK
IQV or IDXX: Which Is the Better Value Stock Right Now? - sharewise.com
Earnings Outlook For IQVIA Hldgs - Benzinga
IQVIA Holdings earnings on deck amid clinical research trends - Investing.com
Value Recap: Is IQVIA Holdings Inc in a long term uptrend2025 Macro Impact & Fast Moving Market Watchlists - baoquankhu1.vn
IQVIA (IQV) Reports Q4: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Is IQVIA Holdings Inc stock influenced by commodity prices2025 Fundamental Recap & AI Enhanced Trading Signals - baoquankhu1.vn
IQVIA (NYSE:IQV) Shares Down 12.5%Time to Sell? - MarketBeat
IQVIA Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
IQVIA Holdings Inc (IQV) Stock Price Down 9.18% on Feb 3 - GuruFocus
Agree To Purchase IQVIA Holdings At $165, Earn 6.4% Using Options - Nasdaq
IQVIA Set to Report Q4 Earnings: Here's What You Should Know - Yahoo Finance
Unlocking Q4 Potential of IQVIA (IQV): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance
(IQV) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Running Oak Capital LLC Sells 8,331 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Is IQVIA Holdings stock outperforming the S&P 500? - MSN
A Closer Look At IQVIA Holdings Inc.'s (NYSE:IQV) Impressive ROE - Yahoo Finance
Mediolanum International Funds Ltd Boosts Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
National Pension Service Increases Position in IQVIA Holdings Inc. $IQV - MarketBeat
New York State Common Retirement Fund Reduces Stake in IQVIA Holdings Inc. $IQV - MarketBeat
Aug Weekly: Is IQVIA Holdings Inc stock showing strong momentumQuarterly Portfolio Review & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Bank of New York Mellon Corp Purchases 20,385 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Ritter Daniher Financial Advisory LLC DE Acquires Shares of 4,267 IQVIA Holdings Inc. $IQV - MarketBeat
Truist Financial Corp Has $29.43 Million Position in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Collaboration With Sarah Cannon Puts Clinical Trial Role In Focus - Sahm
Iqvia, Boehringer Ingelheim Form Long-Term Data Partnership to Power Global Commercial Analytics - marketscreener.com
Iqvia (IQV) Partners with Boehringer Ingelheim for Data Transfor - GuruFocus
Ruffer LLP Sells 104,917 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
How a new IQVIA–Boehringer data pact links drug sales across 59 countries - Stock Titan
J. Safra Sarasin Holding AG Trims Stock Position in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA (IQV) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Market Leaders: Will Massimo Group face regulatory challengesGlobal Markets & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Iqvia Holdings Inc Stock (IQV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):